The presented study explores opportunities for improving the efficiency of financial business support institutions with the purpose of enhancing the competitiveness of the regional economy.Aim. The study aims to identify opportunities and new tools for stimulating economic activity in regions through institutional business support measures.Tasks. The authors analyze the current performance and adequacy of financial business support tools utilized by development institutions at the regional level (through the example of the Rostov region) and formulate proposals on financial business support.Methods. This study uses general scientific methods of cognition (analysis, generalization, economic modeling, etc.) to examine the efficiency of business support provided by development institutions in various aspects and to identify the major directions for improving their operation.Results. Given the current economic situation in the national and global financial markets, the ability of regions to provide financial support to entrepreneurs (in particular, by reducing the cost of application of borrowed funds) is a key factor of their investment attractiveness. As a result, it is possible to achieve sustainable economic growth, which lays the foundation for the long-term competitiveness of the regional economy.Conclusion. Expanding the scope of institutional financial support at the meso-level in the basic non-resource industries and implementing a policy to support and maintain the financial stability of systemic companies in the region facilitates entrepreneurial activity and contributes to the development of the regional economy.
This chapter uses the relationship between behavioral factors and the creditworthiness of small-scale enterprises to increase access of SMEs to credit facilities. The inability of several small businesses to secure loans cannot be overemphasized. Heuristics affecting entrepreneurs are explained in this chapter, and a regression model showing the dependence of creditworthiness on behavioral factors is proposed. If banks consider using psychometric tools in testing for creditworthiness of small-scale entrepreneurs, access to credit facilities will be significantly increased and businesses will flourish. Regressesion models such as the one explained in this chapter may be imbedded in psychometric tools to enhance creditworthiness testing and improve the quality of loans that banks give.
Effective and safe treatment of patients with polymorbidity is an urgent task of modern healthcare. Of particular difficulty is the treatment of patients with cardiovascular comorbidity, which requires an integrated approach to the treatment and development of a special, so-called patient-oriented approach. Modern scientific evidence proposes the use of levocarnitine, as part of complex therapy to increase its effectiveness. So, it was shown that levocarnitine can have a beneficial effect on blood pressure in patients with hypertension, especially those who are overweight and obese. Levocarnitine is also effective in the treatment of heart failure, which has been studied in several clinical studies, which demonstrated its ability to increase the ejection fraction of the left ventricle, stroke volume of blood and other indicators. Optimization of the bioavailability of nitrogen oxide (NO) and a decrease in systemic oxidative stress while taking levocarnitine plays an important positive role in complex therapy in patients with coronary artery disease: exertional angina and post-infarction cardiosclerosis, reducing the number of anginal attacks. Since levocarnitine has powerful antioxidant effects, it also has the neuroprotective effect found in in vitro studies in animal experiments. In case of impaired renal function, due to accelerated elimination and impaired reabsorption, a deficiency of levocarnitine in the body tissues develops, and therefore the US Food and Drug Administration (US FDA) decided on the possibility of using levocarnitine in patients on hemodialysis. Thus, taking into account the positive effects of levocarnitine in a number of frequently combined diseases, it can be considered as the drug of choice in the treatment of patients with polymorbidity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.